ERCC1 and ovarian carcinoma: Most importantly, despite ERCC1 function correlating with chemotherapy response in carcinoma (e.g. lung, bladder, ovarian cancers), only non-carcinoma (melanoma or sarcoma) cell lines were used in the two previous studies focusing on ERCC1 degradation/ubiquitylation [16, 17].